Clinical Trials Browser

INDUSTRY × Non-squamous Non-small-cell Lung Cancer × camrelizumab × Clear all

NCT04619433 2025-09-23

A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.

Phase 3 Terminated

Non-squamous Non-small-cell Lung Cancer